Additive prognostic value of the SYNTAX score over GRACE, TIMI, ZWOLLE, CADILLAC and PAMI risk scores in patients with acute ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention

International Journal of Cardiovascular Imaging

Volumn 29, Issue 6, 2013, Pages 1215-1228

  Brkovic, Voin ^a   Dobric, Milan ^a   Beleslin, Branko ^a,b   Giga, Vojislav ^a   Vukcevic, Vladan ^a,b   Stojkovic, Sinisa ^a,b   Stankovic, Goran ^a,b   Nedeljkovic, Milan A ^a,b   Orlic, Dejan ^a,b   Tomasevic, Miloje ^a   Stepanovic, Jelena ^a,b   Ostojic, Miodrag ^a,b  

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Prognostic value; ST segment elevation myocardial infarction; SYNTAX score

Indexed keywords

ACUTE DISEASE; ADULT; AGED; ARTICLE; CALCULATION; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CONTROLLED ABCIXIMAB AND DEVICE INVESTIGATION TO LOWER LATE ANGIOPLASTY COMPLICATION RISK SCORE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLOBAL REGISTRY OF ACUTE CORONARY EVENTS RISK SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE; PRIMARY ANGIOPLASTY IN MYOCARDIAL INFARCTION RISK SCORE; PROGNOSIS; SCORING SYSTEM; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SYNTAX SCORE; THROMBOLYSIS IN MYOCARDIAL INFARCTION RISK SCORE; VERY ELDERLY; ZWOLLE RISK SCORE;

ADULT; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; DECISION SUPPORT TECHNIQUES; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84893660550     PISSN: 15695794     EISSN: 15730743     Source Type: Journal    
DOI: 10.1007/s10554-013-0202-1     Document Type: Article

References (33)

1. Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K, van den Brand M, Van Dyck N, Russell ME, Mohr FW, Serruys PW (2005) The syntax score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 1:219-227
2. Serruys PW, Onuma Y, Garg S, Sarno G, van den Brand M, Kappetein AP, Van Dyck N, Mack M, Holmes D, Feldman T, Morice MC, Colombo A, Bass E, Leadley K, Dawkins KD, van Es GA, Morel MA, Mohr FW (2009) Assessment of the syntax score in the syntax study. EuroIntervention 5:50-56
3. Garg S, Girasis C, Sarno G, Goedhart D, Morel MA, Garcia-Garcia HM, Bressers M, van Es GA, Serruys PW (2010) The syntax score revisited: a reassessment of the syntax score reproducibility. Catheter Cardiovasc Interv 75:946-952
4. Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, Stahle E, Feldman TE, van den Brand M, Bass EJ, Van Dyck N, Leadley K, Dawkins KD, Mohr FW (2009) Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 360:961-972
5. Kappetein AP, Feldman TE, Mack MJ, Morice MC, Holmes DR, Stahle E, Dawkins KD, Mohr FW, Serruys PW, Colombo A (2011) Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the syntax trial. Eur Heart J 32:2125-2134
6. Holmes DR, Vazales B, Cannon LA, Stahle E, Morice MC, Mack MJ, Feldman TE, Kappetein AP, Colombo A, Dawkins KD, Mohr FW, Serruys PW (2011) Tct-228: four year follow-up of the syntax trial: optimal revascularization strategy in patients with three-vessel disease and/or left main disease. J Am Coll Cardiol 58:B61
7. Mohr FW, Morice MC, Kappetein AP, Feldman TE, Stahle E, Mack MJ, Colombo A, Holmes DR, Dawkins KD, Serruys PW (2012) Final five-year follow-up of the syntax trial: optimal revascularisation strategy in patients with three-vessel disease and/ or left main disease (abstract 2992). Eur Heart J 33:500
8. Serruys PW, Onuma Y, Garg S, Vranckx P, De Bruyne B, Morice MC, Colombo A, Macaya C, Richardt G, Fajadet J, Hamm C, Schuijer M, Rademaker T, Wittebols K, Stoll HP (2010) 5-year clinical outcomes of the arts II (arterial revascularization therapies study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions. J Am Coll Cardiol 55:1093-1101
9. Valgimigli M, Serruys PW, Tsuchida K, Vaina S, Morel MA, van den Brand MJ, Colombo A, Morice MC, Dawkins K, de Bruyne B, Kornowski R, de Servi S, Guagliumi G, Jukema JW, Mohr FW, Kappetein AP, Wittebols K, Stoll HP, Boersma E, Parrinello G (2007) Cyphering the complexity of coronary artery disease using the syntax score to predict clinical outcome in patients with three-vessel lumen obstruction undergoing percutaneous coronary intervention. Am J Cardiol 99:1072-1081
10. Capodanno D, Di Salvo ME, Cincotta G, Miano M, Tamburino C (2009) Usefulness of the syntax score for predicting clinical outcome after percutaneous coronary intervention of unprotected left main coronary artery disease. Circ Cardiovasc Interv 2:302-308
11. Capodanno D, Capranzano P, Di Salvo ME, Caggegi A, Tomasello D, Cincotta G, Miano M, Patane M, Tamburino C, Tolaro S, Patane L, Calafiore AM (2009) Usefulness of syntax score to select patients with left main coronary artery disease to be treated with coronary artery bypass graft. JACC Cardiovasc Interv 2:731-738
12. Onuma Y, Girasis C, Piazza N, Garcia-Garcia HM, Kukreja N, Garg S, Eindhoven J, Cheng JM, Valgimigli M, van Domburg R, Serruys PW (2010) Long-term clinical results following stenting of the left main stem: insights from research (rapamycin-eluting stent evaluated at rotterdam cardiology hospital) and t-search (taxus-stent evaluated at rotterdam cardiology hospital) registries. JACC Cardiovasc Interv 3:584-594
13. Wykrzykowska JJ, Garg S, Girasis C, de Vries T, Morel MA, van Es GA, Buszman P, Linke A, Ischinger T, Klauss V, Corti R, Eberli F, Wijns W, Morice MC, di Mario C, van Geuns RJ, Juni P, Windecker S, Serruys PW (2010) Value of the syntax score for risk assessment in the all-comers population of the randomized multicenter leaders (limus eluted from a durable versus erodable stent coating) trial. J Am Coll Cardiol 56:272-277
14. Lemesle G, Bonello L, de Labriolle A, Steinberg DH, Roy P, Pinto Slottow TL, Torguson R, Kaneshige K, Xue Z, Suddath WO, Satler LF, Kent KM, Lindsay J, Pichard AD, Waksman R (2009) Prognostic value of the syntax score in patients undergoing coronary artery bypass grafting for three-vessel coronary artery disease. Catheter Cardiovasc Interv 73:612-617
15. Magro M, Nauta S, Simsek C, Onuma Y, Garg S, van der Heide E, van der Giessen WJ, Boersma E, van Domburg RT, van Geuns RJ, Serruys PW (2011) Value of the syntax score in patients treated by primary percutaneous coronary intervention for acute st-elevation myocardial infarction: the MI SYNTAXscore study. Am Heart J 161:771-781
16. Scherff F, Vassalli G, Surder D, Mantovani A, Corbacelli C, Pasotti E, Klersy C, Auricchio A, Moccetti T, Pedrazzini GB (2011) The syntax score predicts early mortality risk in the elderly with acute coronary syndrome having primary PCI. J Invasive Cardiol 23:505-510
17. Magro M, Nauta ST, Simsek C, Boersma E, van der Heide E, Regar E, van Domburg RT, Zijlstra F, Serruys PW, van Geuns RJ (2012) Usefulness of the syntax score to predict "no reflow" in patients treated with primary percutaneous coronary intervention for st-segment elevation myocardial infarction. Am J Cardiol 109:601-606
18. Garg S, Sarno G, Serruys PW, Rodriguez AE, Bolognese L, Anselmi M, De Cesare N, Colangelo S, Moreno R, Gambetti S, Monti M, Bristot L, Bressers M, Garcia-Garcia HM, Parrinello G, Campo G, Valgimigli M (2011) Prediction of 1-year clinical outcomes using the syntax score in patients with acute st-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the strategy (single highdose bolus tirofiban and sirolimus-eluting stent versus abciximab and bare-metal stent in acute myocardial infarction) and multistrategy (multicenter evaluation of single high-dose bolus tirofiban versus abciximab with sirolimus-eluting stent or bare-metal stent in acute myocardial infarction study) trials. JACC Cardiovasc Interv 4:66-75
19. Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, Van De Werf F, Avezum A, Goodman SG, Flather MD, Fox KA (2003) Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 163:2345-2353
20. Morrow DA, Antman EM, Charlesworth A, Cairns R, Murphy SA, de Lemos JA, Giugliano RP, McCabe CH, Braunwald E (2000) Timi risk score for st-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous npa for treatment of infarcting myocardium early ii trial substudy. Circulation 102:2031-2037
21. De Luca G, Suryapranata H, van't Hof AW, de Boer MJ, Hoorntje JC, Dambrink JH, Gosselink AT, Ottervanger JP, Zijlstra F (2004) Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty: implications for early discharge. Circulation 109:2737-2743
22. Halkin A, Singh M, Nikolsky E, Grines CL, Tcheng JE, Garcia E, Cox DA, Turco M, Stuckey TD, Na Y, Lansky AJ, Gersh BJ, O'Neill WW, Mehran R, Stone GW (2005) Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. J Am Coll Cardiol 45:1397-1405
23. Addala S, Grines CL, Dixon SR, Stone GW, Boura JA, Ochoa AB, Pellizzon G, O'Neill WW, Kahn JK (2004) Predicting mortality in patients with st-elevation myocardial infarction treated with primary percutaneous coronary intervention (PAMI risk score). Am J Cardiol 93:629-632
24. The InTIME-II Investigators (2000) Intravenous npa for the treatment of infarcting myocardium early; intime-II, a doubleblind comparison of single-bolus lanoteplase vs accelerated alteplase for the treatment of patients with acute myocardial infarction. Eur Heart J 21:2005-2013
25. The TIMI Study Group (1985) The thrombolysis in myocardial infarction (TIMI) trial. Phase I findings. Timi study group. N Engl J Med 312:932-936
26. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ (2005) Recommendations for chamber quantification: a report from the American society of echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European association of echocardiography, a branch of the European society of cardiology. J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr 18:1440-1463
27. Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159-174
28. Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143:29-36
29. Palmerini T, Genereux P, Caixeta A, Cristea E, Lansky A, Mehran R, Dangas G, Lazar D, Sanchez R, Fahy M, Xu K, Stone GW (2011) Prognostic value of the syntax score in patients with acute coronary syndromes undergoing percutaneous coronary intervention: analysis from the acuity (acute catheterization and urgent intervention triage strategy) trial. J Am Coll Cardiol 57:2389-2397
30. Genereux P, Palmerini T, Caixeta A, Cristea E, Mehran R, Sanchez R, Lazar D, Jankovic I, Corral MD, Dressler O, Fahy MP, Parise H, Lansky AJ, Stone GW (2011) Syntax score reproducibility and variability between interventional cardiologists, core laboratory technicians, and quantitative coronary measurements. Circ Cardiovasc Interv 4:553-561
31. Stone GW, Grines CL, Cox DA, Garcia E, Tcheng JE, Griffin JJ, Guagliumi G, Stuckey T, Turco M, Carroll JD, Rutherford BD, Lansky AJ (2002) Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 346:957-966
32. Thygesen K, Alpert JS, White HD (2007) Universal definition of myocardial infarction. Eur Heart J 28:2525-2538
33. Soreide K (2009) Sensitivity and specificity in diagnostic accuracy: ROC solid or lost in translation? J Clin Pathol 62:1051-1052